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EmbolizationAbstract Introduction: Pelvic congestion syndrome (PCS), is a condition associated with ovarian
vein (OV) incompetence among other causes. It is manifested by chronic pelvic pain with associated
dyspareunia and dysmenorrhea. The diagnosis of PCS is often overlooked and the management can
be difficult. Traditional therapy for PCS has included both medical and surgical approaches and
more recently endovascular therapy.
The aim of this work: The aim of this work was to assess the clinical efficacy of ovarian vein
embolization in treatment of PCS associated with OV incompetence and in the management of pel-
vic varices via catheter directed coil embolization.
Conclusion: From our and previous results, we can conclude that catheter directed OV coil
embolization is a feasible procedure for treatment of pelvic congestion syndrome associated with
OV incompetence. Presence of bilateral OV incompetence should always be investigated prior this
therapy. Further prospective trials are required to assess the full benefits and efficacy of this tech-
nique, and to assess which may be the best embolic agent.
 2016 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Chronic pelvic pain (CPP) is a significant health problem in
women particularly during childbearing age and may account
for 10% of outpatient gynecologic visits.1,2 Etiology of chronic
pelvic pain includes irritable bowel syndrome, endometriosis,
adenomyosis, pelvic congestion syndrome, atypical menstrual
pain, urologic disorders, and psychosocial issues.3,4
Pelvic congestion syndrome occurs mostly because of ovar-
ian vein reflux, but can also occur because of the obstruction of
ovarian vein outflow resulting in reversed flow.5Ovarian vein reflux (OVR) is found and PCS is diagnosed
most frequently in multiparous women. During pregnancy,
ovarian vein flow may increase up to 60 times. This increase
in blood flow causes ovarian vein dilatation and may result
in venous valve incompetence. PCS is likely caused by the
incompetence of the venous valves of the ovarian and pelvic
veins, which results in OVR leading to ovarian and pelvic vein
dilatation and stasis. Therefore incompetence, venous reflux,
and dilatation of the ovarian veins lead to the development
of pelvic varicosities and congestion, which are known causes
of pelvic pain and the most likely etiology of PCS.6
The presence of OVR by itself does not make the diagnosis
of PCS. But venous reflux in the ovarian veins of patients with
CPP and with no other identifiable cause of organic pain
makes the diagnosis of PCS.6
Figure 1 (a and b) Mailed questionnaire.
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pelvic pain, dyspareunia, and persistent genital arousal.5 The
pelvic pain of PCS may vary along the menstrual cycle and
worsen during menses and be exacerbated by conditions that
may increase congestion such as the upright position, bending
and lifting, and coitus. The pelvic pain may be described as
fullness and heaviness. The pelvic examination may demon-
strate pelvic tenderness, congestion of the vaginal walls, and
varices.6 Pelvic varices can be seen in 10% of women in the
general population and up to 60% of patients with pelvic
varices may develop pelvic congestion syndrome. Varices can
be seen in the vulva, buttocks, and legs.5Venography, CT, MRI, and Doppler US can demonstrate
OVR. Noninvasive imaging such as sonography, MR, or CT
not only may demonstrate the retrograde ovarian vein flow
but also may exclude other pelvic pathologies that may be
the cause of CPP as well as determine the size of the ovarian
veins, and the presence of pelvic varicosities.6 MRI is prefer-
able as it avoids the large radiation dose associated with CT,
which should be avoided where possible in young women.
For PCS, an ovarian vein diameter of 8 mm on CT or MRI
is considered diagnostic.7
Non-steroidal anti-inflammatory drugs may help relieve
pain in the short term but these are not a long-term solution
Figure. 1 (continued)
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treatment but symptoms should not be ignored if it is not
completely effective or pain recurs when it is stopped.8
Hysterectomy and bilateral oophorectomy with hormone
replacement are said to be an effective cure or at least symp-
tomatic improvement in two-thirds of patients with PCS.9 This
surgical option, however, is not as effective as ovarian vein
ligation, which has been reported as having a 73% cure rate
with 78% of patients showing symptomatic improvement.
However, ligation also cuts nerves to the pelvis and allowsthe establishment of collateral channels and recurrence of
symptoms. Surgery is rarely used these days because endovas-
cular treatments are more effective and less invasive.8
Unlike ligation, endovascular embolization of the ovarian
vein leaves the nerves that accompany the vein intact. Though
it does allow the establishment of collaterals, these are limited
by occlusion of collaterals that drain into the high ovarian
vein.8
Significant pulmonary embolic disease due to migration of
embolic material does not seem to be a complication of
Figure 2 (a) Selective left ovarian vein (OV) venography
showing dilated OV. (b) Left OV occlusion with multiple coils
(6 mm in diameter). (c) Selective right ovarian venography in the
same sitting shows dilated right OV. (d) Multiple coils are placed
in the right OV and venography immediately after embolization
demonstrates occlusion of the right OV.
Figure 3 (a) Transfemoral selective left ovarian venography
shows dilated left OV and pelvic venous engorgement. (b) Left OV
is successfully embolized in a caudocranial direction.
18 H. Abdelsalamembolizing the ovarian veins. Spasm and occasional rupture of
the thin-walled ovarian vein can occur but this rarely leads to
any sequelae and can be treated with simple analgesia.8
2. Material and methods
This study was conducted on 11 patients over a period of
3 years.
The mean age of the patients was 39.8 years with a range of
31–52 years. All patients were uniparous or multiparous.
10 patients presented with lower abdominal pain and vulval
varicosities, 5 of them had thigh varicose veins as well. One
patient had no pelvic pain symptoms, but presented with thigh
varices; the Doppler scan of this patient suggested pelvic
source of the varices.
Five patients had unilateral left OV embolization and 6 had
bilateral OV embolization; in 5 patients bilateral embolizationwas performed in the same sitting, while the remaining patient
underwent staged embolization. Embolization was performed
using Spirale coils (Pyramed, Australia) in all patients.
Outpatient clinical assessment and mailed questionnaires
(Fig. 1) were conducted 3–72 months post-embolization with
a mean follow-up period of 28.1 months.
2.1. Procedure
The procedure was performed under local anesthesia. After
puncture of the right femoral vein with a 5-French sheath
(Cordis, Johnson & Johnson Medical, Diegem, Belgium), a
cobra catheter (Cook Medical Inc, Bloomington, USA) was
advanced into the left renal vein. Subsequently, the left ovarian
vein was catheterized and a venogram was performed. The
right ovarian vein is selectively catheterized directly into the
IVC below the level of the right renal vein.
Embolization was performed with Spirale coils (Pyramed,
Australia). After embolization, repeat venography was per-
formed to confirm OV thrombosis, and the patency of the left
renal vein.
The criteria for embolization included the following: an OV
diameter of more than 8 mm, moderate to severe congestion of
the ovarian plexus, and filling of the contralateral pelvic veins.
Parallel OV trunks that entered the main trunk or that directly
entered the left renal vein were embolized as well.
3. Results
Intraprocedural ovarian venography confirmed presence of
pelvic varices in all 11 patients.
Table 1 Clinical outcome of ovarian vein coil embolization in PCS in different studies.
Abdelsalam Kwon et al. 12 Cordts et al. 13 Capasso et al. 14 Bachar et al. 15
Number of patients in the study 11 67 11 19 6
Procedural success rate 100% 100% 88.9% 96.7% 100%
Immediate complications Nil 3% coil migration 36.4% (3 contrast extravasation,
1 coil migration)
N/A (Not available) Nil
Pelvic pain relief 70% 82% 88.9% 73.7% 83.3%
Mean follow-up period (months) 28.1 39.4 13.4 15.4 7.3
Recurrence of symptoms 10% N/A 22.2% 26.3% N/A
Outcome of ovarian vein embolization 19The procedural success rate was 100%; 5 patients had
unilateral left OV embolization and 6 had bilateral OV
embolization.
Post-embolization pelvic pain relief and relief of vulval
varices were encountered in 7 of 10 patients (70%) by
3 months after the procedure.
Recurrent pelvic pain and vulval varices occurred in 1
patient (10%) after 6 months of embolization.
Improvement of thigh varicosities was reported in 4 of 6
patients (66.7%).
No significant complications encountered in the study
group regarding coil migration, contrast extravasation, or
puncture site hematoma (see Figs. 2 and 3).
4. Discussion
Women who report intermittent or continuous pelvic pain and
have no apparent disease have to be considered potential can-
didates for pelvic congestion syndrome. The pelvic pain is
often described as fullness or heaviness, has a variable intensity
and duration, and often worsens pre-menstrually.10 Ovarian
vein embolization has been used for many years as a treatment
for OVS resistant to medical therapy. Coil embolization, first
described in 1993.11
Our results were comparable to other studies of clinical out-
come of ovarian vein coil embolization in PCS, as summarized
in Table 1.
We did not encounter any post-procedural complications,
and other studies reported low rate of coil migration 3%12
and 9.1%13. Coil migration could happen if the coil was not
sized correctly, or if it was inserted too close to the renal vein.
Pelvic vein relief was variable ranging from partial to com-
plete relief in all studies; in our study 7 out of the 10 patients
with pelvic pain showed partial or complete relief, and our
results were comparable to others. Pain recurrence occurred
in 10% of cases in our study compared to 22–26% in other
studies.13,14
The clinical outcome of the patients did not differ accord-
ing to whether the patient has unilateral or bilateral insuffi-
cient ovarian veins on retrograde venography, and the same
finding was reported by Maleux et al.10
In Kwon et al.12, 13.4% of patients underwent surgery to
get relief from persistent pain after embolization. None of
our patients underwent surgery following embolization.
Pelvic congestion syndrome is a clinical entity that is often
disregarded; therefore, clinicians who do not include trans-
vaginal ultrasound with color Doppler in the diagnostic evalu-
ation of chronic pelvic pain continue to refer these women for
psychotherapy, with a presumed diagnosis of undetectableorganic disease.16 Hence the relative small number of patients
in most of the studies, including ours.
5. Conclusion
From our and previous results, we can conclude that catheter
directed OV coil embolization is a feasible procedure for treat-
ment of pelvic congestion syndrome associated with OV incom-
petence. Presence of bilateral OV incompetence should always
be investigated prior to this therapy. Further prospective trials
are required to assess the full benefits and efficacy of this tech-
nique, and to assess which may be the best embolic agent.
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